Skip to content

ATTAC™ Antigen-Targeted Therapy Against Cancer

A powerful new personalised anti-cancer vaccine program, based on the patient’s own cancer mutations

Published: 27th January 2020
ATTAC™ Antigen-Targeted Therapy Against Cancer
catalin, stock.adobe.com
Patents
  • Provisional patent applications are being developed that protect 1. The clinical monitoring of metastases development and 2. The method of determining the optimal personalized neoantigen selection.
Seeking
  • Commercial partner
  • Development partner